Recorlev and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Recorlev (levoketoconazole), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Vitamin B12, and have Cushing's syndrome.

The phase IV clinical study analyzes which people have Drowsiness when taking Recorlev. It is created by eHealthMe based on reports of 225 people who have side effects when taking Recorlev from the FDA, and is updated regularly.

What is Recorlev?

Recorlev has active ingredients of levoketoconazole. eHealthMe is studying from 226 Recorlev users. Check the latest studies of Recorlev.

What is Drowsiness?

Drowsiness is found to be associated with 2,865 drugs and 4,797 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Jul, 22, 2026

225 people reported to have side effects when taking Recorlev.
Among them, 20 people (8.89%) have Drowsiness.

Among these 20 people:

How long have people been on Recorlev when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Recorlev? *

female: 80 %
male: 20 %

What is the age of people who have Drowsiness when taking Recorlev? *

What are other drugs people take besides Recorlev? *

What are other side effects people have besides Drowsiness? *

Fatigue (feeling of tiredness): 19 people, 95.00%
Headache (pain in head): 9 people, 45.00%
Dizziness: 9 people, 45.00%
Joint Pain: 8 people, 40.00%
Stress And Anxiety: 8 people, 40.00%
Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 7 people, 35.00%
Nausea (feeling of having an urge to vomit): 7 people, 35.00%
Insomnia (sleeplessness): 6 people, 30.00%
Blood Glucose Decreased: 6 people, 30.00%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 6 people, 30.00%

What are the existing conditions these people have? *

Cushing's Syndrome (obesity, a rounded face, increased fat): 16 people, 80.00%
Thyroid Cancer: 5 people, 25.00%
Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 2 people, 10.00%
High Blood Pressure: 1 person, 5.00%
Ectopic Acth Syndrome (a type of cancer-usually associated with the lung): 1 person, 5.00%
Diabetes: 1 person, 5.00%
Blood Test Abnormal: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Recorlev and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Recorlev:

Recorlev (226 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Recorlev:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,865 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,797 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levoketoconazole (the active ingredients of Recorlev) and Recorlev (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.